# Hereditary Angioedema

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Martindale Pharma
- Award value: £74,500,000
- Tender value: £74,500,000
- Award date: 20 June 2022
- Published: 20 July 2022
- Contract start: 1 July 2022
- Contract end: 31 December 2023
- Stage: awarded
- Procurement category: goods
- Notice ID: 1132440f-b206-4c8a-9c65-84276d8d2f77-556317
- OCID: ocds-b5fd17-5242c430-9651-453d-9ccd-71a66de32b6f

## Description

NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema\. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 30 months\. Total maximum framework agreement including extension options will be no more than 48 months

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/1132440f-b206-4c8a-9c65-84276d8d2f77-556317)